Psoriasis in nonwhite patient populations is not well described, according to Andrew F. Alexis, M.D., M.P.H., director of the Skin of Color Center, at St. Luke’s Roosevelt Hospital, Mount Sinai Health System, New York.
While government funds for research in dermatology and other medical specialties seems to be dwindling, there are forces at work that could help to pick up at least part of the slack.
Dermatologists are using an evolving collection of combination therapies designed to address different aspects of disease, monotherapy limitations and failures, as well as enhance treatment.
Women and men are not always created equal when it comes to their dermatologic concerns, frequency and presentation of several dermatologic conditions, treatment options and outcomes.
Barbara Mathes, M.D., started her healthcare career as an emergency room nurse. She remembers answering medical residents' questions, and the residents would tell her she might as well go into medicine. Her reply? "One day I think I will." So started a multifaceted professional life in dermatology, which has included private practice, teaching, industry work, research and more.
Advances in cosmetic and medical skin treatments are helping dermatologists both to avoid and to treat hyperpigmentation and other conditions in patients with Fitzpatrick skin types IV-VI, says Pearl E. Grimes, M.D., F.A.A.D., director of the Vitiligo and Pigmentation Institute of Southern California, Los Angeles.
Janet Gratner Hickman, M.D., may have retired from full-time private practice more than a year ago, but life since has been anything but leisurely. For Dr. Hickman, the close of three decades in dermatology practice meant more time for giving back to the specialty, to research and to her beloved daffodils.
Physicians' relationships with industry have long been an ethical tug of war, yet they remain commonplace. And with government's increasing focus on transparency — augmented with the U.S. Supreme Court upholding of the Patient Protection and Affordable Care Act — consulting, research and other relationships with pharmaceutical and medical device companies will become even more visible.
Dermatologist Rashmi Sarkar, M.D., doesn't see the more than 7,000 miles separating her home country from the United States as a networking obstacle. In fact, she has taken a special interest in bringing the worlds of dermatology in India and America together.
Thursday’s five-to-four vote by the U.S. Supreme Court to uphold the Patient Protection and Affordable Care Act (ACA) as constitutional will result in sweeping healthcare system changes for patients and their doctors.